Fibroblast Growth Factor 21 Prevents Diabetic Cardiomyopathy by Attenuating Cardiac Lipotoxicity via Erk1/2-dependent Signaling Pathway in Mice

被引：0
|
作者：
Tan, Yi [1 ]
Zhang, Chi [1 ]
Yan, Xiaoqing [1 ]
Huang, Zhifeng [2 ]
Gu, Junlian [1 ]
Zhou, Shanshan [1 ]
Shao, Minglong [2 ]
Feng, Wenke [1 ]
Li, Xiaokun [2 ]
机构：
[1] Univ Louisville, Louisville, KY 40292 USA
[2] Wenzhou Med Univ, Wenzhou, Peoples R China
来源：
CIRCULATION RESEARCH | 2015年 / 117卷
关键词：
Fibroblast growth factor 21; Diabetic cardiomyopathy; Cardiac lipotoxicity;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
26
引用
收藏
页数：1
相关论文
共 50 条
  • [31] AKT and ERK1/2 activation via remote ischemic preconditioning prevents Kcne2-dependent sudden cardiac death
    Hu, Zhaoyang
    Liu, Jin
    Zhou, Leng
    Tian, Xin
    Abbott, Geoffrey W.
    [J]. PHYSIOLOGICAL REPORTS, 2019, 7 (03):
  • [32] Up-regulated HMGB1 in EAM directly led to collagen deposition by a PKCβ/Erk1/2-dependent pathway: cardiac fibroblast/myofibroblast might be another source of HMGB1
    Su, Zhaoliang
    Yin, Jingping
    Wang, Ting
    Sun, Yingkun
    Ni, Ping
    Ma, Rui
    Zhu, Haitao
    Zheng, Dong
    Shen, Huiling
    Xu, Wenlin
    Xu, Huaxi
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2014, 18 (09) : 1740 - 1751
  • [33] Dual Specific Phosphatase 7 Exacerbates Dilated Cardiomyopathy, Heart Failure, and Cardiac Death by Inactivating the ERK1/2 Signaling Pathway
    Jing Liu
    Yihen Yin
    Jing Ni
    Peiyu Zhang
    Wei-ming Li
    Zheng Liu
    [J]. Journal of Cardiovascular Translational Research, 2022, 15 : 1219 - 1238
  • [34] Dual Specific Phosphatase 7 Exacerbates Dilated Cardiomyopathy, Heart Failure, and Cardiac Death by Inactivating the ERK1/2 Signaling Pathway
    Liu, Jing
    Yin, Yihen
    Ni, Jing
    Zhang, Peiyu
    Li, Wei-ming
    Liu, Zheng
    [J]. JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2022, 15 (06) : 1219 - 1238
  • [35] The Selective Serotonin 2A Receptor Antagonist Sarpogrelate Prevents Cardiac Hypertrophy and Systolic Dysfunction via Inhibition of the ERK1/2-GATA4 Signaling Pathway
    Shimizu, Kana
    Sunagawa, Yoichi
    Funamoto, Masafumi
    Honda, Hiroki
    Katanasaka, Yasufumi
    Murai, Noriyuki
    Kawase, Yuto
    Hirako, Yuta
    Katagiri, Takahiro
    Yabe, Harumi
    Shimizu, Satoshi
    Sari, Nurmila
    Wada, Hiromichi
    Hasegawa, Koji
    Morimoto, Tatsuya
    [J]. PHARMACEUTICALS, 2021, 14 (12)
  • [36] FGF21 Expresses in Diabetic Hearts and Protects from Palmitate- and Diabetes-Induced Cardiac Cell Death In Vitro and In Vivo via Erk1/2-Dependent p38 MAPK-AMPK Signaling Pathways
    Zhang, Chi
    Miao, Xiao
    Bai, Yang
    Chen, Qiang
    Li, Xiaokun
    Cai, Lu
    [J]. DIABETES, 2012, 61 : A56 - A57
  • [37] Fibroblast growth factor-2 represses platelet-derived growth factor receptor-α (PDGFR-α) transcription via ERK1/2-dependent Sp1 phosphorylation and an atypical cis-acting element in the proximal PDGFR-α promoter
    Bonello, MR
    Khachigian, LM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (04) : 2377 - 2382
  • [38] Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway
    Xu, Zheng
    Tong, Qian
    Zhang, Zhiguo
    Wang, Shudong
    Zheng, Yang
    Liu, Qiuju
    Qian, Ling-Bo
    Chen, Shao-Yu
    Sun, Jian
    Cai, Lu
    [J]. CLINICAL SCIENCE, 2017, 131 (15): : 1841 - 1857
  • [39] Inhibition of HDAC3 Prevents Diabetic Cardiomyopathy in OVE26 Mice via Epigenetic Regulation of DUSP5-ERK1/2 Pathway
    Xu, Zheng
    Sun, Jian
    Cai, Lu
    [J]. DIABETES, 2017, 66 : A123 - A123
  • [40] Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/ 2 pathway
    Xu, Zheng
    Sun, Jian
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C40 - C41
12345